Purchase Order AG5615P170101
Award Date 5/11/17
Potential Completion Date 9/29/17
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a $11,051.04 firm fixed price contract award on June 29, 2016, under a Blanket Purchase Agreement (BPA) call vehicle with the Southeast Area of a civilian federal agency. The contract, designated FC-402-4022, calls for delivery of a High Sequence Rapid SBS Kit V2 (50 Cycles) plus one complementary unit, with an ultimate completion date of September 9, 2019. No...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a contract award on March 20, 2018, through a Blanket Purchase Agreement (BPA) call with a civilian federal agency's Southeast Area office. The contract, valued at $8,256.23 with a firm fixed price structure, covers the procurement of Nextera XT DNA Library Preparation Kit, Index Kit, High Output Kit, and PhiX Control Kit—specialized reagent kits essential for...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a delivery order from a civilian federal agency's Northeast Area office for Illumina reagent kits valued at $39,121.64. This firm fixed-price contract, awarded on May 3, 2024, with a completion date of December 31, 2024, will be performed in Orient, New York. The delivery order procures laboratory equipment, consumables, and services without a set-aside...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- Illumina, Inc. was awarded a Firm Fixed Price Purchase Order valued at $21,465.60 by the Pacific West Area, a civilian federal agency, on January 31, 2018, with an ultimate completion date of May 31, 2018. The contract covers an Illumina iSelect Custom Kit for oat genetic analysis, with performance to be completed in San Diego, California. This award was not designated as a set-aside contract, reflecting Illumina's specialized capabilities in genomic sequencing technologies. The contract was...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing technologies, was awarded a $35,052.16 firm fixed price call under a Blanket Purchase Agreement (BPA) on December 15, 2015, for NextEra XT DNA Sample Kits. This contract, which carried no set-aside designation, reflected Illumina's specialized capabilities in providing advanced genomic sequencing consumables and reagents. The award was funded by a civilian federal agency (Plains Area) with a completion...
- Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Purchase Order for a NEOPREP LIBRARY MACHINE valued at $57,210 by a civilian federal agency within the Midwest Area. The contract, issued on August 3, 2016, with an ultimate completion date of August 4, 2017, utilizes Firm Fixed Price pricing with no set-aside designation. The place of performance is San Diego, California, where Illumina maintains its headquarters...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Library Kit contract valued at $3,206 by the Plains Area civilian agency through a Blanket Purchase Agreement (BPA) call on July 31, 2015. The contract utilized firm fixed pricing with no set-aside designation and was scheduled for ultimate completion on September 9, 2019. The place of performance was located in San Diego, California, reflecting Illumina's...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a $91.6K firm fixed-price delivery order from the Plains Area office, a civilian agency, for Illumina Reagents and laboratory equipment, consumables, and services. The contract was awarded on September 16, 2022, with an ultimate completion date of September 13, 2023, with performance to be conducted in San Diego, California. This delivery order does not carry a...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a purchase order contract by the U.S. Department of Agriculture's Midwest Area on February 1, 2018, for the RNA RiboZero Gold Preparation Kit. The contract, which utilized no set-aside designation and carried a ceiling value of $17,136.29 under a firm fixed-price arrangement, was scheduled for ultimate completion on February 28, 2018. This purchase order was...